Dosing Adjustments for Cyp3a4 Substrate Medications in Liver Impairment
Medications that are substrates of the cytochrome P450 3A4 (Cyp3A4) enzyme often require careful dose adjustments in patients with liver impairment. Since the liver is the primary site for drug metabolism, compromised liver function can significantly alter drug clearance and increase the risk of toxicity. Understanding Cyp3A4 and Liver Impairment Cyp3A4 is one of the … Read more